ClinVar Miner

Submissions for variant NM_000124.4(ERCC6):c.466C>T (p.Gln156Ter) (rs751838040)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Knight Diagnostic Laboratories,Oregon Health and Sciences University RCV000193828 SCV000223926 likely pathogenic Cockayne syndrome B 2014-08-12 criteria provided, single submitter clinical testing
Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics RCV000224212 SCV000280636 pathogenic not provided 2015-05-14 criteria provided, single submitter clinical testing
GeneDx RCV000224212 SCV000329858 pathogenic not provided 2017-11-30 criteria provided, single submitter clinical testing The Q156X pathogenic variant in the ERCC6 gene has been reported previously in an individual with Cockayne syndrome who also harbored another ERCC6 variant (Laugel et al., 2010). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Q156X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret Q156X as a pathogenic variant.
Counsyl RCV000666322 SCV000790594 likely pathogenic DE SANCTIS-CACCHIONE SYNDROME; Cerebro-oculo-facio-skeletal syndrome; Cockayne syndrome B 2017-03-29 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.